SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Identifying AWaRe indicators for appropriate antibiotic use: a narrative review

Funiciello, E; Lorenzetti, G; Cook, A; Goelen, J; Moore, CE; Campbell, SM; Godman, B; Tong, D; Huttner, B; Chuki, P; et al. Funiciello, E; Lorenzetti, G; Cook, A; Goelen, J; Moore, CE; Campbell, SM; Godman, B; Tong, D; Huttner, B; Chuki, P; Sharland, M (2024) Identifying AWaRe indicators for appropriate antibiotic use: a narrative review. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 79 (12). pp. 3063-3077. ISSN 0305-7453 https://doi.org/10.1093/jac/dkae370
SGUL Authors: Sharland, Michael Roy Moore, Catrin Elisabeth Cook, Aislinn Jane

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Supplementary data) Supplemental Material
Download (365kB)
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (132kB)

Abstract

Introduction Quality indicators (QIs) are widely used tools for antibiotic stewardship programmes. The Access, Watch, Reserve (AWaRe) system has been developed by the WHO to classify antibiotics based on their spectrum of activity and potential selection of antibiotic resistance. This review aimed to identify existing indicators for optimal antibiotic use to inform the development of future AWaRe QIs. Methods A literature search was performed in PubMed. We included articles describing QIs for hospital and primary healthcare antibiotic use. We extracted information about (i) the type of infection; (ii) setting; (iii) target for quality assessment; and (iv) methodology used for the development. We then identified the indicators that reflected the guidance provided in the AWaRe system. Results A total of 773 indicators for antibiotic use were identified. The management of health services and/or workers, the consumption of antibiotics, and antibiotic prescribing/dispensing were the principal targets for quality assessment. There was a similar distribution of indicators across primary and secondary care. For infection-specific indicators, about 50% focused on respiratory tract infections. Only a few QIs included information on review treatment or microbiological investigations. Although only 8 (1%) indicators directly cited the AWaRe system in the wording of the indicators, 445 (57.6%) indicators reflected the guidance provided in the AWaRe book. Conclusions A high number of indicators for appropriate antibiotic use have been developed. However, few are currently based directly on the WHO AWaRe system. There is a clear need to develop globally applicable AWaRe based indicators that can be integrated into antibiotic stewardship programmes.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: 0605 Microbiology, 1108 Medical Microbiology, 1115 Pharmacology and Pharmaceutical Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
ISSN: 0305-7453
Dates:
DateEvent
December 2024Published
18 October 2024Published Online
25 September 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
222051/Z/20/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
Web of Science ID: WOS:001335035200001
URI: https://openaccess.sgul.ac.uk/id/eprint/116914
Publisher's version: https://doi.org/10.1093/jac/dkae370

Actions (login required)

Edit Item Edit Item